CD58 and acute lymphoblastic leukemia: We also validated the overall diagnostic outcome of the ALB tube; here, we asked whether the CD58 included in the ALB tubes offered any additional diagnostic advantage in identifying a B-ALL that had been identified in the first-line ClearLLab 10C investigation.